$BKHAU

Black Hawk Acquisition (BKHA) reported $25.15M in share redemptions ahead of its merger with Vesicor, leaving $420K in trust and 2.06M shares outstanding. The redemptions reduce available deal cash.

Black Hawk Acquisition Corp. (BKHAU, BKHA, BKHAR) announced that 2.09 million shareholders redeemed their shares, generating $25M in payments. The redemption is related to its proposed business combination with Vesicor Therapeutics Inc. (VESI), a preclinical-stage biotech company. The combined entity is expected to list on NASDAQ under the symbol VESI.

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of a Matter to a Vote of Security Holders. On October 13, 2026, Black Hawk Acquisition Corporation (the “Company”) held an extraordinary general meeting of Shareholders (the “Extraordinary General Meeting”). The record date for shareholders entitled to notice

Wolverine Asset Management, Wolverine Holdings, and two managers reported a 5.09% stake in Black Hawk Acquisition Corp., owning 211,220 shares each. Wolverine Holdings and the managers also claim beneficial ownership of 221,220 shares, with shared voting and dispositive power. The percentages are based on 4,153,577 outstanding shares as of July 15, 2026, according to the filing.

Black Hawk Acquisition Corp (BKHA) reported Q3 2026 net income of $1.07M, up 596.6% YoY, with EPS of $0.26, up 766.7%. Revenue grew mid-single digits YoY, driven by core products and e-commerce. Management expects continued margin improvement and modest top-line growth.

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i

Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the

This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.

This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.